Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9200 posts found.

Syngene launches new platform for protein production

June 6, 2024 Research and Development ExcellGene, Pharmacy, Syngene, platform, protein production

Syngene has announced the launch of its new protein production platform, which will utilise a cell line and transposon-based technology …
News

Gilead shares results from two-year analysis of phase 3 study in primary biliary cholangitis

June 5, 2024 Research and Development Gilead, Hepatology, clinical trials, primary biliary cholangitis, seladelpar

Gilead has announced two-year interim results from the ongoing ASSURE study of investigational seladelpar for the treatment of primary biliary …
News
testalize-me-0je8ynv4mis-unsplash

Sanofi shares phase 3 trial results for Sarclisa in multiple myeloma treatment

June 5, 2024 Research and Development Oncology, Sanofi, Sarclisa, clinical trial, multiple myeloma

Sanofi has announced data from the IMROZ phase 3 trial which assessed Sarclisa (isatuximab) in combination with standard-of-care bortezomib, lenalidomide …
News

Gilead and Arcus announce results from colorectal cancer treatment trial

June 3, 2024 Research and Development Arcus, Gilead, Oncology, clinical trial, colorectal cancer

Gilead Sciences and Arcus Biosciences have announced new data from cohort B of ARC-9, a phase 1b/2 study which aims …
News

OSE Immunotherapeutics and Boehringer Ingelheim collaborate on cancer and cardio-renal-metabolic disease treatments

May 24, 2024 Research and Development Boehringer Ingelheim, Cancer, Cardiology, OSE Immunotherapeutics, cardio-renal-metabolic diseases

OSE Immunotherapeutics and Boehringer Ingelheim have announced a major expansion of their existing partnership. The expansion includes two new projects …
News

Nona Biosciences announced agreement with AstraZeneca for tumour targeted therapies

May 24, 2024 Research and Development AstraZeneca, Cancer, Oncology, nona biosciences, targeted therapies

Nona Biosciences and AstraZeneca have announced that the two companies have entered into a license agreement for preclinical monoclonal antibodies, …
News

Sanofi, Formation Bio and OpenAI enter AI collaboration

May 22, 2024 Research and Development Formation Bio, OpenAI, Pharmacy, Sanofi, collaboration

Sanofi, Formation Bio and OpenAI have announced that they have entered into a collaboration with the aim of building AI-powered …
News

GSK shares positive results from phase 3 asthma trials

May 21, 2024 Research and Development Asthma & COPD, GSK, asthma, clinical trial

GSK has announced positive headline results from its phase 3 SWIFT-1 and SWIFT-2 trials, which evaluated the safety and efficacy …
News

ERS Genomics and IRBM sign license agreement for CRISPR/Cas9

May 20, 2024 Research and Development CRISPR/Cas9, ERS Genomics, IRBM, License Agreement, Pharmacy

ERS Genomics and IRBM have announced that they have entered into a non-exclusive CRISPR/Cas9 license agreement, granting IRBM access to …
News
diana-polekhina-zbsthwt9vlc-unsplash_2

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024 Research and Development AstraZeneca, COVID-19, Immunology, clinical trial

AstraZeneca has announced positive high-level results from the SUPERNOVA phase 3 trial for a COVID-19 pre-exposure prophylaxis treatment, sipavibart (formerly …
News

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024 Research and Development AMR, Fleming Initiative, GSK, Microbiology, funding

GSK has announced that it has pledged £45m to the Fleming Initiative, becoming the first founding partner of the innovative …
News

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024 Research and Development NeuroSense, Neurology, als, clinical trials

NeuroSense has announced that it has partnered with PhaseV for its upcoming phase 3 trial of PrimeC as a treatment …
News

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024 Research and Development AstraZeneca, BenevolentAI, Cardiology, collaboration, heart failure

BenevolentAI has announced that AstraZeneca has added a novel heart failure target to its discovery portfolio following the two companies’ …
News

Fulcrum Therapeutics and Sanofi enter collaboration for facioscapulohumeral muscular dystrophy treatment

May 14, 2024 Research and Development Musculo-skeletal disorder, Sanofi, collaboration, fulcrum therapeutics, muscular dystrophy

Fulcrum Therapeutics has announced that it has entered into a collaboration and license agreement with Sanofi for the development and …
News
dementia image

Nxera Pharma partner Neurocrine Biosciences enters phase 1 NBI-1117567 study

May 9, 2024 Research and Development Alzheimer's disease, Neurocrine Biosciences, Neurology, Nxera Pharma, Parkinson's disease, clinical trials, dementia, schizophrenia

Nxera Pharma’s neuroscience-focused biopharmaceutical partner  Neurocrine Biosciences has announced it has successfully started its phase 1, first-in-human trial of investigational …
News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024